These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse. Thornburg JE; Moore KE Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378 [No Abstract] [Full Text] [Related]
5. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat]. Cohen Y; Wepierre J; Jacquot C; Rapin J Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419 [No Abstract] [Full Text] [Related]
6. The mode of action of -methyldopa. Day MD; Roach AG; Whiting RL Br J Pharmacol; 1972 May; 45(1):168P-169P. PubMed ID: 5041485 [No Abstract] [Full Text] [Related]
7. [Methods of determination of the turnover rate of neuromediators (author's transl)]. Poitou P; Bohuon C Pathol Biol (Paris); 1976 Feb; 24(2):149-52. PubMed ID: 5695 [TBL] [Abstract][Full Text] [Related]
8. Dopa decarboxylase in medullary carcinoma of the thyroid. Atkins FL; Beaven MA; Keiser HR N Engl J Med; 1973 Sep; 289(11):545-8. PubMed ID: 4146664 [No Abstract] [Full Text] [Related]
9. [Derivatives of dithiocarbamic acid as inhibitors of catecholamine biosynthesis (review of the literature)]. Korablev MV; Kurbat NM Farmakol Toksikol; 1977; 40(2):230-8. PubMed ID: 15863 [No Abstract] [Full Text] [Related]
10. Studies on the mechanism of the L-3,4-dihydroxyphenylalanine-induced decrease in tyrosine hydroxylase activity. Dairman W; Udenfriend S Mol Pharmacol; 1972 May; 8(3):293-9. PubMed ID: 4402746 [No Abstract] [Full Text] [Related]
11. Inhibition of norepinephrine biosynthesis by -methyl amino acids in the guinea-pig vas deferens. Thoa NB; Johnson DG; Kopin IJ J Pharmacol Exp Ther; 1972 Jan; 180(1):71-7. PubMed ID: 4551586 [No Abstract] [Full Text] [Related]
12. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates. Vogel WH; Mahoney K; Hare TA Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242 [No Abstract] [Full Text] [Related]
13. Biosynthesis and metabolism of endogenous tyramine and its normal presence in sympathetic nerves. Tallman JF; Saavedra JM; Axelrod J J Pharmacol Exp Ther; 1976 Oct; 199(1):216-21. PubMed ID: 10424 [TBL] [Abstract][Full Text] [Related]
14. Catecholamines and the hydroxylation of tyrosine in synaptosomes isolated from rat brain. Karobath M Proc Natl Acad Sci U S A; 1971 Oct; 68(10):2370-3. PubMed ID: 4400211 [TBL] [Abstract][Full Text] [Related]
15. Effect of different dopa decarboxylase inhibitors on the hypotensive response to alpha-methyldopa in rats. Henning M Br J Pharmacol; 1968 Sep; 34(1):233P-234P. PubMed ID: 5676035 [No Abstract] [Full Text] [Related]
16. The anticonvulsant effect of carbonic anhydrase inhibitors in mice--a noradrenergic mechanism of action. Torchiana ML; Lotti VJ; Stone CA Eur J Pharmacol; 1973 Mar; 21(3):343-9. PubMed ID: 4145319 [No Abstract] [Full Text] [Related]
17. Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain. Korduba CA; Veals J; Symchowicz S J Pharmacol Exp Ther; 1974 Sep; 190(3):459-65. PubMed ID: 4413186 [No Abstract] [Full Text] [Related]
18. Poststimulation catecholamine synthesis and tyrosine hydroxylase activation in central noradrenergic neurons. I. In vivo stimulation of the locus coeruleus. Salzman PM; Roth RH J Pharmacol Exp Ther; 1980 Jan; 212(1):64-73. PubMed ID: 6101343 [TBL] [Abstract][Full Text] [Related]